Dr. Masoud Qasemi, added that surgical risk is high in patients suffering from aortic stenosis, since they are old and have a history of previous heart surgery.
TAVR, also known as Transcatheter Aortic Valve Implantation (TAVI), is a procedure for select patients with severe symptomatic aortic stenosis (narrowing of the aortic valve opening) who are not candidates for traditional open chest surgery or are high-risk operable candidates.
The replacement surgery is performed on a beating heart and does not require cardio-pulmonary bypass. The TAVR valve is supported with a metal stent.
A catheter is placed in the femoral artery (in the groin) similar to angioplasty and guided into the chambers of the heart. A compressed tissue heart valve is placed on the balloon catheter and positioned directly inside the diseased aortic valve. Once in position, the balloon is inflated to secure the valve in place.
This procedure is performed with general anesthesia. A team of interventional cardiologists and heart surgeons work together to guide the valve to the site of the patient’s diseased heart valve.
“The surgery will be performed on the sidelines of the 16th National Congress on Cardiovascular Update on two patients suffering from aortic stenosis,” he said.
The congress will be held at Tehran’s Razi International Conference Center from September 16-19.
Distinguished Iranian and foreign experts will attend the four-day event, which will focus on the latest significant achievements in treating cardiovascular diseases.
Updating the skills and knowledge of Iranian experts in treating cardiovascular diseases is the main goal of the congress.
**1425
Tehran, Sept 15, IRNA - A cardiology team will perform the first Transcatheter Aortic Valve Replacement (TAVR) in Iran, said the head of the Iranian Society of Atherosclerosis.
